Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
25.87 CHF | -1.98% |
|
-2.92% | +2.82% |
06-28 | US urges dismissal of lawsuit seeking menthol cigarette ban | RE |
06-24 | European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading | MT |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
- The company appears to be poorly valued given its net asset value.
- The company has a low valuation given the cash flows generated by its activity.
- This company will be of major interest to investors in search of a high dividend stock.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
- As estimated by analysts, this group is among those businesses with the lowest growth prospects.
- The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
- One of the major weak points of the company is its financial situation.
- With an enterprise value anticipated at 3.26 times the sales for the current fiscal year, the company turns out to be overvalued.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Sector: Tobacco
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+2.82% | 68.04B | - | ||
+7.71% | 158B | B- | ||
+12.04% | 21.69B | A- | ||
+45.69% | 7.44B | B- | ||
+95.57% | 2.57B | - | C+ | |
-2.30% | 1.79B | - | ||
-6.29% | 1.66B | - | D+ | |
-28.42% | 1.18B | - | B+ | |
0.00% | 641M | - | - | |
+21.92% | 565M | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- BATS Stock
- BATS Stock
- Ratings British American Tobacco p.l.c.